Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids.
about
Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgeryThe variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomyLittle evidence for association of the glaucoma gene MYOC with open-angle glaucoma.Emerging drugs for ophthalmic diseases.Cut and paste: a no suture, small incision approach to pterygium surgery.Treating Sjögren's Syndrome: Insights for the ClinicianEfficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucomaGraft failure: III. Glaucoma escalation after penetrating keratoplasty.Feline glaucoma--a comprehensive review.Management of seasonal allergic conjunctivitis: guide to therapy.Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?Clinical Applications of Dexamethasone for Aged Eyes.Rimexolone-induced intraocular pressure elevation.Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome.The differential diagnosis of red eye: a survey of medical practitioners from Eastern Europe and the Middle East.
P2860
Q28244137-00897136-0A87-4CC3-93EC-238710677833Q33287406-CF95E5CE-B0BE-400E-9A74-31352B173831Q33446334-59354730-FDAB-4349-BAF7-55AE78442DBAQ35581180-D9B9C2B8-90BA-4190-AA7D-A58E4A4789B6Q35592254-344D1531-93EF-4F46-9E58-FBBB6AAE19C9Q36056942-ABABEE00-EBF5-45E4-A899-6F286A16CB83Q36281352-2560D08A-C422-442A-96F8-350A83F9DED2Q37145908-E739AD86-7574-400F-A940-AC39A4A26246Q37933484-5DDE7D78-BFA0-492B-AF51-F2028EFAE561Q37954005-D8071812-F3D7-4BAF-BD60-CA41F821A475Q38019465-127C4CA2-9E1F-4298-BF83-4739A53EC1C2Q38241140-BE40AFBF-E16A-43C9-814B-7B13B48E4A6AQ38938500-D107FCF5-D325-4777-9287-272CB3702A61Q43795356-BBA0583C-088E-40E3-9BB4-45D20E8DEE4CQ46366385-A6CC885E-D07D-4F78-93C6-EA7CB3503991Q48344821-5A6F2FEE-C916-4066-9594-0372132124EFQ50731295-443954EE-0941-4F73-8E65-4D390FF4B914
P2860
Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Intraocular pressure-raising p ...... responding to corticosteroids.
@en
Intraocular pressure-raising p ...... responding to corticosteroids.
@nl
type
label
Intraocular pressure-raising p ...... responding to corticosteroids.
@en
Intraocular pressure-raising p ...... responding to corticosteroids.
@nl
prefLabel
Intraocular pressure-raising p ...... responding to corticosteroids.
@en
Intraocular pressure-raising p ...... responding to corticosteroids.
@nl
P2093
P1433
P1476
Intraocular pressure-raising p ...... responding to corticosteroids.
@en
P2093
P304
P356
10.1001/ARCHOPHT.1996.01100140141005
P407
P577
1996-08-01T00:00:00Z